Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02483923Completed
Randomised trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Yonsei University. Primary endpoint: Total opioid consumption at 24 hours. Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02483923.